Price$4.32+0.01 (+0.23%)
01:30 PM07:45 PM
News · 26 weeks27+14%
2025-12-142026-06-07
Mix2290d
- Insider12(55%)
- SEC Filings7(32%)
- Earnings2(9%)
- Dividends1(5%)
Latest news
25 items- INSIDERDirector Marshall Joseph W Iii converted options into 24,116 shares and returned $31,762 worth of shares to the company (7,235 units at $4.39), increasing direct ownership by 7% to 246,523 units (SEC Form 4) (withholding tax)4 - SIGA TECHNOLOGIES INC (0001010086) (Issuer)
- INSIDERDirector Keane John M converted options into 24,116 shares and returned $31,762 worth of shares to the company (7,235 units at $4.39) (SEC Form 4) to satisfy withholding obligation4 - SIGA TECHNOLOGIES INC (0001010086) (Issuer)
- INSIDERDirector Ford Harold Eugene Jr. converted options into 24,116 shares and returned $31,762 worth of shares to the company (7,235 units at $4.39), increasing direct ownership by 55% to 47,538 units (SEC Form 4) (withholding obligation)4 - SIGA TECHNOLOGIES INC (0001010086) (Issuer)
- INSIDERDirector Phillips Holly L. converted options into 24,116 shares and returned $31,762 worth of shares to the company (7,235 units at $4.39), increasing direct ownership by 30% to 73,754 units (SEC Form 4) to cover withholding tax4 - SIGA TECHNOLOGIES INC (0001010086) (Issuer)
- INSIDERDirector Nemirovsky Julian converted options into 24,116 shares and returned $31,762 worth of shares to the company (7,235 units at $4.39), increasing direct ownership by 30% to 73,754 units (SEC Form 4) to satisfy withholding obligation4 - SIGA TECHNOLOGIES INC (0001010086) (Issuer)
- INSIDERDirector Durnan Jaymie A converted options into 24,116 shares and returned $31,762 worth of shares to the company (7,235 units at $4.39), increasing direct ownership by 23% to 88,754 units (SEC Form 4) (tax liability)4 - SIGA TECHNOLOGIES INC (0001010086) (Issuer)
- INSIDERDirector Nabel Gary J. converted options into 24,116 shares and returned $31,762 worth of shares to the company (7,235 units at $4.39), increasing direct ownership by 30% to 73,754 units (SEC Form 4) (for tax liability)4 - SIGA TECHNOLOGIES INC (0001010086) (Issuer)
- SECSIGA Technologies Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - SIGA TECHNOLOGIES INC (0001010086) (Filer)
- SECSEC Form DEFA14A filed by SIGA Technologies Inc.DEFA14A - SIGA TECHNOLOGIES INC (0001010086) (Filer)
- SECSEC Form 10-Q filed by SIGA Technologies Inc.10-Q - SIGA TECHNOLOGIES INC (0001010086) (Filer)
- SECSIGA Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SIGA TECHNOLOGIES INC (0001010086) (Filer)
- PRSIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business UpdateOn Track to Deliver $13 Million of Oral TPOXX to an International Customer in Second QuarterExpect to Deliver $26 Million of IV TPOXX to the U.S. Government Strategic National Stockpile by End of the Third Quarter Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three months ended March 31, 2026. "Consistent with our long-term strategy, we expect to deliver more than $35 million of oral and IV TPOXX to a combination of the U.S. Government and an international customer across the second and third quarters of 2026,"
- PRSIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial ResultsNEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, May 7, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at http://www.siga.com in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738
- SECSEC Form DEFA14A filed by SIGA Technologies Inc.DEFA14A - SIGA TECHNOLOGIES INC (0001010086) (Filer)
- SECSEC Form DEF 14A filed by SIGA Technologies Inc.DEF 14A - SIGA TECHNOLOGIES INC (0001010086) (Filer)
- INSIDERSEC Form 4 filed by Miller Larry R.4 - SIGA TECHNOLOGIES INC (0001010086) (Issuer)
- SECSIGA Technologies Inc. filed SEC Form 8-K: Other Events8-K - SIGA TECHNOLOGIES INC (0001010086) (Filer)
- PRSIGA Declares Special Cash Dividend of $0.60 Per ShareNEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that its board of directors declared a special cash dividend of $0.60 per share on the company's common stock. The amount of this dividend is consistent with the level of the special dividend declared in April 2025. The dividend is payable on April 23, 2026, to shareholders of record at the close of business on April 7, 2026. "Today's announcement of a special cash dividend reflects the strength of our balance sheet and focus on maximizing shareholder value," said Diem Nguyen, Chief Executive Officer. "We remain committed to executing our st
- INSIDERExecutive VP & CFO Luckshire Daniel J converted options into 11,503 shares and covered exercise/tax liability with 6,074 shares, increasing direct ownership by 2% to 280,493 units (SEC Form 4)4 - SIGA TECHNOLOGIES INC (0001010086) (Issuer)
- INSIDEREVP & Chief Scientific Officer Hruby Dennis E converted options into 11,445 shares and covered exercise/tax liability with 3,955 shares, increasing direct ownership by 4% to 198,537 units (SEC Form 4)4 - SIGA TECHNOLOGIES INC (0001010086) (Issuer)
- INSIDERGeneral Counsel Miller Larry R. covered exercise/tax liability with 11,187 shares and converted options into 21,261 shares, increasing direct ownership by 26% to 48,518 units (SEC Form 4)4 - SIGA TECHNOLOGIES INC (0001010086) (Issuer)
- INSIDERChief Executive Officer Nguyen Diem converted options into 85,045 shares and covered exercise/tax liability with 47,029 shares, increasing direct ownership by 38% to 138,767 units (SEC Form 4)4 - SIGA TECHNOLOGIES INC (0001010086) (Issuer)
- SECSEC Form 10-K filed by SIGA Technologies Inc.10-K - SIGA TECHNOLOGIES INC (0001010086) (Filer)
- SECSIGA Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SIGA TECHNOLOGIES INC (0001010086) (Filer)
- PRSIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business UpdateGenerated TPOXX Product Revenues of $88 Million in 2025 Received $13 Million International Procurement Order for Oral TPOXX in January 2026 Corporate Update Conference Call Today at 4:30 PM ET NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and twelve months ended December 31, 2025. "In 2025, we continued to advance SIGA's key long-term priorities, including securing $27 million in additional U.S. Government funding to support development activities, while generating $88 million in product revenues and $24 million in pre-tax operating income," stated Diem
SIGA FAQ
5 questionsWhat does SIGA Technologies Inc. do?
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was founded in 1995 and is headquartered in New York, New York.Where does SIGA stock trade?
SIGA Technologies Inc. (SIGA) is listed on NASDAQ.What sector and industry is SIGA in?
SIGA Technologies Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.What companies are similar to SIGA?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare SIGA side-by-side with any of them on Quantisnow.How can I track SIGA on Quantisnow?
Quantisnow aggregates SIGA Technologies Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SIGA to receive live email and push alerts on every new disclosure.